# Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

> **NCT00806286** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 111 (actual)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer

## Interventions

- **DRUG:** CS7017 tablets
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **DRUG:** Placebo Tablets

## Key facts

- **NCT ID:** NCT00806286
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-01
- **Final completion:** 2012-08
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806286, "Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00806286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*